Cdk9 inhibitor and use thereof

The present invention relates to the field of medicines, specifically relates to a CDK9 inhibitor compound represented by formula (I), and a pharmaceutically acceptable salt or isomer thereof, and also relates to a pharmaceutical composition and pharmaceutical preparation of the compound and a use t...

Full description

Saved in:
Bibliographic Details
Main Authors YOKOSAKA Takuya, WANG Wuwei, WU Frank, KAWASAKI Masanori, MIYANO Natsumi, LI Lin
Format Patent
LanguageEnglish
Hebrew
Published 01.08.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of medicines, specifically relates to a CDK9 inhibitor compound represented by formula (I), and a pharmaceutically acceptable salt or isomer thereof, and also relates to a pharmaceutical composition and pharmaceutical preparation of the compound and a use thereof. X1, X2, R1, R2, R3, R6, A, L, n, and m are as defined in the description. The compound can be used in the preparation of a drug for treating or preventing CDK9-mediated related diseases.
Bibliography:Application Number: IL20240313513